Technology evaluation: A critical step in the clinical utilization of novel diagnostic tests for liver fibrosis
- 30 April 2007
- journal article
- editorial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 46 (4), 543-545
- https://doi.org/10.1016/j.jhep.2007.01.008
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infectionHepatology, 2006
- Performance of serum marker panels for liver fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- Assessment of liver fibrosis in co-infected patientsJournal of Hepatology, 2005
- Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C InfectionClinical Chemistry, 2005
- Can serum markers be used to reliably detect liver fibrosis?Nature Clinical Practice Gastroenterology & Hepatology, 2005
- Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patientsJournal of Hepatology, 2004
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- Serum markers detect the presence of liver fibrosis: A cohort studyGastroenterology, 2004
- Evaluation of Liver Fibrosis: A Concise ReviewThe American Journal of Gastroenterology, 2004
- Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective studyThe Lancet, 2001